DD vs GRCE · P/E 127, rev $12.39B vs $35.0M cap
Dupont De Nemours Inc (DD) versus Grace Therapeutics, Inc. (GRCE) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
GRCE does not have a complete income-statement cache yet.
DD currently screens at market cap $19.61B and trailing P/E 127.4. GRCE currently screens at market cap $35.0M.
Not investment advice. Open the DD and GRCE stock pages for the full models.
Not investment advice.